The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps

Abstract

ESS remains cost effective compared to medical therapy for patients both with and without asthma. While the comorbidity of asthma results in an inferior ICER result, it does not result in a statistically significant negative impact on the overall cost effectiveness of ESS.